Friday, June 08, 2018 9:18:26 AM
Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT)
announces updates on trademark filings and scheduling of clinical trials for
bio-availability of its CannaStripsTM technology.
The CannaStripsTM logo and tagline "Smoke Free Pain Relief" have been issued
European Union trade mark registration numbers 017383712 and 017383738 by
the European Union Intellectual Property Office and the United Kingdom trade
mark registration numbers UK00003265774 and UK00003265768, issued by the
United Kingdom Intellectual Property Office. The Company has also applied
for trademark protection in California. These marks are in addition to the
Canadian trademark applications the Company has filed with the Canadian
Intellectual Property Office on April 25, 2017.
The Company is scheduling clinical trials to commence in June 2018 to define
the bio-availability benefits of the Lifestyle Delivery Systems'
CannaStripsTM technology. These clinical trials are expected to quantify the
enhanced delivery method of CannaStripsTM compared to other forms of
delivery.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM